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Abstract To support expanded prevention services for
people living with HIV, the US Health Resources and
Services Administration (HRSA) sponsored a 5-year ini-
tiative to test whether interventions delivered in clinical
settings were effective in reducing HIV transmission risk
among HIV-infected patients. Across 13 demonstration
sites, patients were randomized to one of four conditions.
All interventions were associated with reduced unprotected
vaginal and/or anal intercourse with persons of HIV-
uninfected or unknown status among the 3,556 participat-
ing patients. Compared to the standard of care, patients
assigned to receive interventions from medical care pro-
viders reported a signiﬁcant decrease in risk after
12 months of participation. Patients receiving prevention
services from health educators, social workers or parapro-
fessional HIV-infected peers reported signiﬁcant reduction
in risk at 6 months, but not at 12 months. While clinics
have a choice of effective models for implementing pre-
vention programs for their HIV-infected patients, medical
provider-delivered methods are comparatively robust.
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Introduction
HIV primary care clinics are an important setting in which
to deliver behavioral HIV prevention interventions because
HIV-infected individuals are likely to be seen in these
settings for regular care four times per year or more. A
growing literature on the importance of delivering pre-
vention interventions to HIV-infected patients (prevention
with positives or PWP) demonstrates that medical care
providers can help patients reduce risk [1–3]. Other types of
prevention service providers have also delivered effective
programs for HIV-infected individuals. For example,
prevention counselors [4], group facilitators [5] and HIV-
infected peers [6] have helped HIV-infected individuals
reduce their risk. However, no study has compared the
effectiveness of HIV prevention interventions delivered in
clinical settings by different types of providers to determine
which interventions work best in helping HIV-infected
patients reduce their risk of transmitting HIV to others.
To determine the relative effectiveness of different types
of prevention programs delivered in clinical settings, the
Special Projects of National Signiﬁcance (SPNS) program
of the Health Resources and Services Administration
(HRSA) funded 15 demonstration sites and an evaluation
and support center to implement and evaluate prevention
interventions for HIV-infected people who were seen in
clinical settings [7]. Sites were required to use intervention
approaches that were based on models that had been shown
to be effective in prior research. Most sites chose inter-
ventions based on the well-tested health behavior theories
of the Transtheoretical Model [8], motivational interview-
ing [9] and/or harm reduction [10]. Table 1 provides an
overview of the theoretical models used by participating
sites. All sites used formative research and expert
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123consultation to tailor these approaches to the local client
population and clinical setting. Detail on the tailoring
processes is available elsewhere [11].
Sites also used a variety of provider types to deliver
intervention services (Table 1). Speciﬁcally, in this study,
medical care provider-delivered interventions used brief
risk assessment via computer to support clinicians in
delivering brief counseling during routine medical visits. In
some sites, social workers or health educators delivered
HIV-prevention counseling. Health educators and social
workers worked alone, with medical providers or with HIV-
infected peers to deliver interventions. Most often, inter-
ventions involved one-on-one client-oriented sessions. In
some sites, these were combined with group sessions. The
number of sessions deﬁning each intervention ranged from
one to nine. In sites where prevention messages were
delivered by more than one type of provider (‘‘multi-pro-
vider interventions’’), medical care providers delivered
prevention messages in clinical encounters; health educa-
tors, social workers or peer educators also conducted risk
assessments and delivered individual counseling sessions
alone or in combination with group sessions. Table 1 also
provides a description of the provider characteristics in each
participating site.
This paper describes the outcomes of the project across
all sites. We present ﬁndings describing whether and to
what degree behavioral interventions in primary care set-
tings help HIV-infected patients reduce the risk of trans-
mitting HIV. We also describe the relative HIV risk
reduction among patients receiving medical care provider-
led interventions, interventions delivered by health educa-
tors, social workers or paraprofessional HIV-infected peers
serving as ‘‘HIV prevention specialists’’ or interventions
delivered by a medical provider and an HIV prevention
specialist (multi-provider interventions) compared to
patients receiving the standard of care.
Methods
Interventions and survey interviews were conducted in
funded sites between April 2004 and December 2006. Sites
were selected based on a competitive application process
and were located in Chapel Hill, NC; Boston, MA; Balti-
more, MD; New York City, NY; Seattle, WA; Sacramento,
CA; San Diego, CA; Birmingham, AL; Philadelphia, PA;
Decatur, GA; Miami, FL; Chicago, IL; and Tucson, AZ.
Some sites had more than one clinic, and all participating
clinics received funding from the federal Ryan White
Program with 300 patients or more. Each site required local
human research subjects approval in addition to the
approval obtained from the University of California, San
Francisco, which served as the cross-site evaluation center.
Although 15 sites were funded through this initiative,
the analysis presented here is restricted to data from 13 of
the sites. The Ofﬁce of AIDS Policy and Planning, Los
Angeles site was omitted because study investigators used
different interviewing procedures and the resulting data
were systematically different from the other 14 sites. Data
from the Whitman Walker Clinic site in Washington, D.C.
was omitted because there was an interruption in the study
due to ﬁscal hardship within the organization; this inter-
ruption resulted in information not being available on
patient receipt of the intervention and assignment to the
intervention or assessment-only conditions.
Study Population
A total of 3,556 HIV-infected patients completed audio-
computer assisted self interviews (ACASI) at baseline.
These interviews included standardized cross-site questions
and additional questions that a site’s study team added and
used in local analysis. The ACASI survey was programmed
using Questionnaire Development System version 2.0 by
Nova Research Company (Bethesda, MD). Inclusion cri-
teria were HIV-infected status, receipt of primary care at
the clinic, age of 18 years or older, and ability to provide
informed consent. For the cross-site evaluation, we trans-
lated the interview instrument into Spanish; however, this
version was used at only one site. All other respondents
were English-speaking. Sites had the option of adding
additional inclusion requirements, which are summarized
in Table 1. The cross-site evaluation survey took approx-
imately 30 minutes to complete.
Recruitment and screening of potential respondents was
undertaken exclusively in medical clinics serving HIV-
infected clients. Sites used a variety of recruitment mate-
rials including brochures, posters, and project descriptions,
as well as direct contact by study staff in clinics. Interested
patients were brieﬂy screened by project personnel to
determine their self-reported HIV status as well as basic
demographic and contact information. Then, eligible par-
ticipants were scheduled for a baseline interview. Screen-
ing took place in a private setting, usually in a room or
quiet place in the clinic. Most sites used incentives worth
approximately $25 such as cash, a grocery voucher, or a
gift certiﬁcate, to encourage participation in the evaluation
portion of the project. Participants were not given incen-
tives to attend intervention visits.
Randomization
Patients were individually randomized to an intervention
group or a comparison condition on a site-by-site basis.
Patients in the intervention group were assigned to receive
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123interventions from their medical care providers during
routine HIV care visits alone or in combination with ser-
vices delivered by health educators, case managers or
social workers or by HIV-infected peers trained to conduct
HIV prevention counseling. Providers delivered interven-
tions as stand alone sessions or in conjunction with routine
clinical visits. Social workers, health educators and HIV-
infected peers hired by these projects served the same role.
In sites that included either medical provider-delivered or
prevention specialist-delivered interventions, patients in
the comparison group received the standard of care, routine
HIV care visits by their medical care provider. Some sites’
interventions used a combination of approaches so that
patients received prevention counseling from both medical
providers and prevention specialists. In these multi-pro-
vider sites, patients in the comparison group received
medical provider-delivered prevention counseling only.
For this analysis, data were combined from patients in sites
where the comparison group received the standard of care
with those in multi-provider sites where the intervention
condition was medical provider prevention only. Inter-
vention and comparison types are summarized in Table 1.
Study Measures
Demographic Characteristics and Health Status Indicators
Detailed background and demographic items included
participant’s age, race/ethnicity, gender, self-identiﬁed
sexual orientation, relationship status, educational level,
employment status, and income. In addition, self-reported
health status indicators were assessed including: most
recent CD4 count, HIV viral load, and current use of
antiretroviral medication.
Sexual Behavior
Participants were asked to report sexual behavior over a
6 month recall period. Separate but equivalent versions of
questions were developed for men and women, each with
language tailored to be consistent with the participant’s
gender and sexual orientation. Participants were asked to
provide the number of times they had engaged in insertive
or receptive vaginal and/or anal sex with HIV-infected
partners, HIV-uninfected partners and partners of unknown
HIV status. Participants were also asked about the number
of times they had used condoms (male or female) from the
beginning to the end of penetration and the number of
times sex was unprotected. Unprotected sex was limited in
the questioning to any act of insertive or receptive anal or
vaginal intercourse in which a participant did not use a
condom, a deﬁnition that excludes risk acts produced by
accidental condom slippage or breakage.
Sexual Transmission Risk
Transmission risk acts were deﬁned as reports of unpro-
tected anal or vaginal intercourse without the use of a
condom with any HIV-uninfected or unknown status
partners. These acts were dichotomized into, ‘‘Yes’’ or
‘‘No.’’ Our outcome indicator does not include sex with
HIV-infected partners because superinfection has not been
observed in individuals such as those participating in this
project, primarily characterized as having been infected for
more than 3 years, engaged in care and on antiretroviral
drugs.
Substance Use
Use of legal and illegal substances was assessed over a
3 month recall period. Items included alcohol, cocaine/
crack, sedatives, tranquilizers, stimulants (such as crystal
methamphetamine), analgesics, inhalants, marijuana, hal-
lucinogens, and heroin. Use of injected drugs was assessed
over the past 30 days. Items included frequency of injec-
tion and whether a participant had lent a needle to someone
else after using it.
Patients repeated the assessments at 6-month intervals
for 12 months after their initial baseline assessment and
randomization.
Statistical Analysis
We compare participant characteristics, sexual behavior
and substance use at study entry by intervention type
using chi-square tests of homogeneity. Patients assigned
to peer or health educator/social worker-led interventions
responded similarly to the interventions with respect to
their sexual transmission risk behavior and were com-
bined in the analysis into a category entitled ‘‘prevention
specialists.’’ We present the prevalence of sexual trans-
mission risk behavior among participants in each inter-
vention type over the 12-month assessment period
graphically (Fig. 1). We compare the odds of sexual
transmission risk behavior among participants in each
intervention type to the odds of sexual transmission risk
behavior among participants in the standard of care group
at each time point using generalized estimating equations
(GEE). In this model, we estimate the odds of sexual
transmission risk behavior among participants in each
intervention type at study entry, 6 months and 12 months
using indicator variables for each intervention type at
each time point. In order to account for clustering of
participant behavior by intervention site, the GEE models
adjust for sexual transmission risk behavior at study
entry, as well as the correlation among participants at
each site and within intervention groups.
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123Because randomization occurred at the level of indi-
vidual sites, rather than across the study as a whole, we
employed inverse probability of treatment weighting
(IPTW) to account for the effect of differences in the
patient populations across intervention types on the
observed effect of each intervention type [12, 13]. This
method has the effect of creating samples in each inter-
vention type that have been weighted to balance out the
distribution of demographic and other patient characteris-
tics associated with sexual transmission risk behavior. This
creates a weighed population where characteristics of
individuals are similar across all intervention types. Esti-
mated parameters thus reﬂect the effect of each interven-
tion type that would have been seen if it were possible to
randomize the treatments across settings.
To estimate these weights, we used categorical logistic
regression to estimate the probability of being assigned to
each intervention type, given an individual’s demographic
characteristics (age, gender, sexual orientation, race/eth-
nicity) and reported substance use (alcohol, speed and/or
injecting drug use) at baseline. Factors in the model were
chosen based on their association with the primary out-
come at baseline, which are described in our paper on
predictors of risk in this population [14]. The inverses of
these probabilities were then applied as weights to the GEE
model described above. However, application of these
weights impacted the observed results by less than 1%.
Therefore, they were not retained in the ﬁnal model.
Because loss to follow-up was different across study
sites and treatment arms, we used additional weighting
methods to assess the impact of loss to follow-up on
observed study results. These methods have the effect of
weighting the data at each follow-up to resemble the
sample at baseline with respect to factors associated with
sexual transmission risk. Estimated parameters thus reﬂect
the expected effect of each intervention type had no loss-
to-follow-up occurred. To estimate these weights, we used
logistic regression to estimate the probability of remaining
in the study at each time point, given an individual’s
demographic and substance use at baseline as deﬁned
above. The inverse of these probabilities were then applied
as inverse probabilities of censoring weights (IPCW) to the
ﬁnal GEE model described above. Application of these
results did impact the observed results. Therefore these
weights were retained in the ﬁnal model. The combination
of the GEE model and the weighting procedures allows us
to generate estimates for the effect of treatment at a pop-
ulation level accounting for differences across sites and the
correlation of individuals results within sites. All analyses
were implemented in SAS (version 9.1, SAS Institute Inc,
Cary, NC).
Results
Participant Characteristics at Study Entry
Participant characteristics by intervention model are pre-
sented in Table 2. Of the 3,556 participants completing
baseline assessments, most participants were men (70%)
and over 40 years of age (64%). Forty-eight percent were
African American, 37% were Caucasian, 11% were His-
panic or Latino and 4% were of mixed or other race/eth-
nicities. Similar proportions of participants identiﬁed as
gay (44%) and heterosexual (45%), while fewer identiﬁed
as bisexual (8%) or of unknown sexual orientation (2%).
Approximately half of participants had a high school
degree and 39% had a paying job. HIV-related health status
among participants was good with 60% reporting CD4? T
cell counts greater than 200 (cells/mm
3) and 15% reporting
CD4? T cell counts less than 200 (cells/mm
3). One quarter
of participants did not know the value of their most recent
CD4? T cell count. One-third of participants reported
having an undetectable viral load, 53% reported having a
detectable viral load and 12% did not know the value of
their most recent viral load test. Two-thirds of participants
reported current use of antiretroviral therapy.
Sexual Behavior and Drug Use in the 6 Months Prior
to Study Entry
Table 3 presents the sexual risk characteristics at baseline
of 3,556 patients across intervention types. Overall, 77% of
patients reported at least one sexual partner in the previous
6 months (n = 2,723). Among patients reporting sexual
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123activity at baseline, the mean number of partners overall
was ﬁve (standard deviation = 11) and the median was 2
(25–75% = 1–3). Thirty-nine percent of sexually active
patients reported two or more partners at baseline. Of these,
1,421 (52%) reported one or more HIV-infected partners,
1,324 (49%) reported one or more HIV-uninfected partners
and 847 (31%) reported one or more partners of unknown
serostatus. Thirty percent reported any vaginal sex.
Twenty-seven percent reported anal insertive sex and 32%
anal receptive sex. Twenty-four percent of participants
reported anal insertive sex with male sexual partners, and
3% reported anal insertive sex with female sexual partners.
Eleven percent of patients reported unprotected vaginal or
anal sex with an uninfected partner. Twenty-one percent
reported unprotected vaginal or anal sex with an HIV-
infected partner and 10% reported unprotected vaginal or
Table 2 Characteristics at baseline of 3,556 study participants
Standard of care
(N = 1055)
Medical care provider
intervention
(N = 768)
Prevention specialist
intervention
(N = 975)
Multi-provider
Intervention
(N = 758)
v
2 P B
Gender 25.1 0.001
Male 781 (74) 490 (64) 705 (72) 530 (72)
Female 269 (26) 270 (35) 265 (27) 224 (27)
Transgender 5 (0.5) 8 (1) 5 (1) 4 (1)
Race/ethnicity 97.5 0.001
White 410 (39) 282 (37) 332 (25) 298 (22)
African American 461 (43) 445 (58) 454 (26) 454 (26)
Hispanic/Latino 142 (13) 22 (3) 140 (25) 125 (23)
Other 42 (4) 19 (2) 49 (31) 23 (15)
Sexual orientation 23.6 0.01
Homosexual 487 (46) 313 (41) 405 (42) 373 (49)
Bisexual 86 (8) 65 (8) 73 (8) 70 (9)
Heterosexual 453 (43) 371 (48) 478 (49) 297 (39)
Unknown/No answer 29 (3) 19 (2) 19 (2) 18 (2)
Age 79.7 0.001
39 or less 335 (32) 345 (45) 271 (28) 327 (43)
40 or more 720 (68) 423 (55) 704 (72) 431 (57)
Education completed 5.2 0.16
High school or less 540 (51) 377 (49) 524 (54) 371 (49)
Some college or more 515 (49) 391 (51) 451 (46) 387 (51)
Unknown/No answer 0 (0) 0 (0) 0 (0) 0 (0)
Employment 36.6 0.001
Unemployed 644 (61) 413 (54) 648 (65) 478 (63)
Employed 411 (39) 355 (46) 324 (33) 279 (37)
Unknown/No answer 0 (0) 0 (0) 3 (0) 1 (0)
CD4 cell count 10.1 0.12
Below 200 152 (14) 109 (14) 154 (16) 120 (16)
200 or above 622 (59) 461 (60) 575 (59) 481 (64)
Unknown/No answer 281 (27) 198 (26) 246 (25) 157 (21)
Most recent viral load 68.7 0.001
Undetectable 381 (36) 216 (28) 418 (43) 219 (29)
Detectable 537 (51) 445 (58) 469 (48) 448 (59)
Unknown/no answer 137 (13) 107 (14) 88 (9) 91 (13)
Currently on ART 29.1 0.001
No 151 (14) 126 (16) 108 (11) 129 (17)
Yes 711 (68) 481 (63) 694 (71) 458 (60)
Unknown/no answer 193 (18) 161 (21) 173 (18) 171 (23)
488 AIDS Behav (2010) 14:483–492
123Table 3 Risk behaviors at baseline of 3,556 study participants
Standard of care
(N = 1055)
Medical care
provider intervention
(N = 768)
Prevention specialist
intervention
(N = 975)
Multi-provider
intervention
(N = 758)
v
2 P
Sexual activity in last 6 months
Sexually active 771 (73) 621 (81) 718 (74) 613 (82) 29.1 0.001
Sexual partners
a
Mean (SD) number of partners 3.8 (9.3) 3.6 (7.8) 4.8 (12.4) 6.2 (12.5)
Median [IQR] 1 (1–3) 1 (1–3) 2 (1–4) 2 (1–5)
Two or more sex partners 379 (49) 298 (48) 363 (51) 338 (55) 7.5 0.060
Serostatus of partners
a
One or more HIV ? Partner/s 400 (52) 319 (51) 367 (52) 335 (55) 1.7 0.63
One or more HIV– Partner/s 391 (51) 307 (49) 327 (47) 299 (49) 2.5 0.48
One or more partners of unknown serostatus 228 (30) 177 (29) 237 (34) 205 (34) 6.4 0.09
Type of sexual activity
a
Any vaginal sex 257 (77) 260 (82) 317 (84) 228 (85) 7.4 0.070
Any anal insertive sex 272 (35) 214 (34) 226 (32) 254 (41) 15.0 0.002
Male sexual partner(s) 247 (54) 192 (59) 196 (55) 229 (63) 8.5 0.040
Female sexual partner(s) 28 (16) 27 (22) 35 (19) 31 (30) 8.5 0.040
Any anal receptive sex 315 (51) 258 (50) 260 (47) 299 (57) 10.2 0.020
Unprotected Sex in last 6 months
Any unprotected vaginal or anal sex 309 (29) 263 (34) 263 (27) 322 (43) 55.6 0.001
Any unprotected vaginal/anal sex with
b
HIV-infected partner 205 (51) 164 (51) 162 (43) 206 (61) 25.0 0.001
HIV-uninfected partner 97 (25) 96 (31) 88 (27) 109 (37) 12.6 0.006
Unknown serostatus partner 82 (36) 74 (42) 87 (37) 105 (51) 13.2 0.005
Injection drug use behavior in last 30 days
c
Injected any drug in past 30 days
c 50 (5) 30 (4) 46 (5) 42 (6) 2.6 0.46
Times injected in past 30 days
d
Mean (SD) 10.7 (14.6) 13.2 (18.5) 10.1 (16.6) 18.2 (29.3)
Median [IQR] 4.5 (3–12) 5 (2–20) 4 (2–10) 7.5 (2–15)
Lent used paraphernalia 1 (2) 3 (10) 3 (7) 6 (14) 5.1 0.16
Alcohol use in last 3 months 5.2 0.81
None 397 (38) 282 (37) 382 (39) 292 (39)
Less than daily 585 (55) 442 (58) 534 (55) 416 (55)
Daily 51 (5) 28 (4) 45 (5) 32 (4)
Unknown/no answer 22 (2) 16 (2) 14 (1) 18 (2)
Stimulant use in last 3 months 91.3 \0.001
No 866 (82) 628 (82) 755 (77) 560 (74)
Cocaine only 121 (11) 88 (11) 153 (16) 77 (10)
Speed only 32 (3) 28 (4) 36 (4) 78 (10)
Cocaine and speed 31 (3) 18 (2) 26 (3) 29 (4)
Unknown/no answer 5 (0) 6 (1) 5 (1) 14 (2)
Other drug use in last 3 months 18.5 \0.005
No 799 (76) 555 (72) 699 (72) 533 (70)
Yes 251 (24) 207 (27) 271 (28) 211 (28)
Unknown/No answer 5 (0) 6 (1) 5 (1) 14 (2)
a Among those who are sexually active
b Among those with HIV-positive, HIV-uninfected or HIV-unknown status partners respectively
c Among all participants
d Among those who injected drugs in the past 30 days
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123anal sex with an unknown status partner. Twenty-one
percent of patients reported transmission risk acts, i.e.
unprotected anal or vaginal intercourse with an HIV-
uninfected or unknown status partner in the last 6 months.
Patient Characteristics by Study Group Assignment
Overall, 30% of participants were assigned to the standard
of care, 22% to a medical care provider-delivered inter-
vention, 27% to a prevention specialist-delivered inter-
vention and 21% to an intervention site using both medical
care providers and prevention specialists to deliver inter-
vention messages (multi-provider intervention). We
observed demographic and clinic differences in patients
assigned to each intervention type (Table 2). Compared to
those assigned to standard of care, participants in the
medical care provider-delivered interventions were more
likely to be women (v
2 = 22.1; P\0.001), younger than
40 years of age (v
2 = 32.2; P\0.001), African American
(v
2 = 76.7; P\0.001), to have a paying job (v
2 = 9.6;
P\0.003) and to report having a detectable viral load
(v
2 = 15.9; P\0.001). Participants in the prevention
specialist-delivered intervention group were more likely
than those in the standard of care to be 40 years of age or
older (v
2 = 4.1; P\0.04), to have a paying job
(v
2 = 10.2; P\0.006) and to report having an undetect-
able viral load (v
2 = 18.5; P\0.001). Participants in the
multi-provider intervention group were more likely than
participants assigned to the standard of care to be younger
than 40 years of age (v
2 = 24.3; P\0.001) and to report
having a detectable viral load (v
2 = 17.7; P\0.004). Par-
ticipants in the multi-provider intervention group were less
likely than participants assigned to standard of care to report
current use of antiretroviral therapy (v
2 = 9.4; P\0.001).
There were also differences in the sexual behavior of
patients receiving prevention different intervention pro-
viders (Table 3). Compared to patients in the standard of
care group, patients in the medical provider-delivered and
prevention specialist-delivered intervention groups repor-
ted similar sexual transmission risk behavior at baseline.
Patients in medical provider-delivered intervention group
were more likely to be sexually active (v
2 = 15.4,
P\0.001) and to report any unprotected vaginal or anal
sex at baseline (v
2 = 5.3, P\0.001), while patients in
prevention specialist-delivered intervention group were
signiﬁcantly more likely to report any vaginal sex and sex
with an HIV-infected partner (v
2 = 5.0, P\0.03).
Patients assigned to receive intervention services from
medical care providers and prevention specialists did not
differ from those in the standard of care group with respect
to unprotected vaginal or anal sex with an HIV-negative or
unknown status partner.
In contrast, compared to patients in the standard of care
group, patients in the multi-provider intervention group
report substantially more sexual transmission risk at base-
line. Patients in the multi-provider intervention group were
signiﬁcantly more likely to report being sexually active
(v
2 = 18.0, P\0.001), to have two or more sex partners
(v
2 = 5.1, P\0.02), to report any vaginal (v
2 = 5.4,
0.02) or anal sex (v
2 = 5.7, 0.02) with male (v
2 = 7.2,
P\0.008) or female (v
2 = 8.0, P\0.005) sex partners,
as well as any unprotected vaginal or anal sex (v
2 = 36.1,
P\0.004) and unprotected vaginal or anal sex with HIV-
infected (v
2 = 8.5, P\0.004), HIV-uninfected (v
2 = 11.0,
P\0.001) and unknown HIV-serostatus (v
2 = 10.2,
P\0.001) partners.
Retention and Completion Rates
At the 12-month follow-up assessment, 58% of patients
were retained in the standard of care group, 76% of patients
were retained in the medical provider intervention group;
62% were retained in the prevention specialist group and
44% in the multi-provider group. There were differences in
retention by patient characteristics. Older, white, gay
patients with more than a high school education but who
did not use cocaine or injection drugs were more likely to
be retained in the study at 12-months.
Sexual Transmission Risk Over Time by Intervention
Assignment
Figure 1 illustrates transmission risk across time points for
the intervention and comparison arms. We observed a
statistically signiﬁcant effect of prevention-specialist-led
interventions at 6 months and medical provider-led inter-
ventions at 12 months. Compared to the standard of care
group, patients in the medical provider-delivered inter-
ventions reported a small effect of the intervention at
6 months (Odds Ratio [OR] = 0.93; 95% Conﬁdence
Interval [CI] = 0.60, 1.20; P\0.79) and a much greater
effect at 12 months (OR = 0.55; 95% CI = 0.32, 0.94;
P\0.03). In contrast, compared to patients assigned to the
standard of care, patients in the specialist-delivered inter-
ventions reported a larger effect of the intervention at
6 months (OR = 0.58; 95% CI = 0.35, 0.96; P\0.04),
but this effect diminished at 12 months (OR = 0.67; 95%
CI = 0.39, 1.14; P\0.14). Participants in the multi-pro-
vider interventions also reported a small reduction in
transmission risk behavior at 6 (OR = 0.89; 95%
CI = 0.53, 1.51; P\0.68) and 12 months (OR = 0.89
(95% CI = 0.53, 1.51; P\0.68) relative to those in the
standard of care group, but these differences were not
statistically signiﬁcant.
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123Discussion
HIV prevention with positives programs delivered by either
medical care providers or HIV prevention specialists are
effective in reducing sexual risk behavior among patients
seen in clinical settings. In this large, multi-site study,
messages delivered by HIV prevention specialists inﬂu-
enced behavior change in the shorter term and medical care
provider-delivered messages were effective after they had
been in place for several months. This study supports
others demonstrating the effectiveness of provider-deliv-
ered health promotion messages [15].
This study also illustrates the importance of tailoring
behavioral interventions to speciﬁc clinical settings.
Although prevention specialist-led interventions were less
likely to inﬂuence longer term behavior changes, they did
create meaningful change at 6-months and may be a good
option for some clinics. The difference in sustained out-
comes may be due to factors associated with implementa-
tion. In provider sites, patients likely received intervention-
related counseling at each medical visit, with more visits
likely to occur and more visits likely to be made closer to
the 12-month assessment point. In prevention specialist
sites, patients usually received counseling in the days or
weeks immediately following the baseline assessment. Our
results suggest that behavioral interventions are most
effective if they are delivered in ‘‘doses’’—such as at
routine medical care visits—over time, which has been
noted in other studies [16].
The sites using a combination of medical care providers
and prevention specialists (‘‘multi-provider’’ sites) did not
demonstrate effectiveness in terms of reduced risk among
patients receiving intervention services. There is evidence
from the qualitative results from this study that these
interventions may be difﬁcult to implement because of the
attention required to train and sustain provider attention
[11]. When a project had to ensure ﬁdelity to an inter-
vention protocol for both medical care providers and pre-
vention specialists within one clinical setting, the effort for
project staff was signiﬁcant and at times, the procedures
were too daunting and/or confusing. It may have been that
the level of resources available for this intervention study
was not great enough to support such complex interven-
tions. It may also be that the complexity of behavioral
interventions combined with supporting different types of
providers in one setting was just too difﬁcult. In any case,
future studies may want to explore issues of quality
assurance and efﬁciency in prevention with positives pro-
jects involving more than one type of provider in a clinical
setting.
Finally, it is important to note that risk assessment alone
seems to inﬂuence risk reduction among patients. As has
been noted in other studies [16, 17], study participants who
were not exposed to any intervention at all still reported
reduced risk during ACASI assessments at 6- and 12-
months. Lightfoot and colleagues have speciﬁcally docu-
mented the effects of self-monitoring via ACASI on
changes in risk behaviors and attitudes [18]. It appears that
simply asking patients to report their risk provides an
opportunity for reﬂection that may serve as a cue for self-
motivated change.
Conclusions drawn from this study are limited to some
degree by the characteristics of the patients who partici-
pated. Most had been infected for 10 years or more and
were adherent to both ARVs and to medical care seeking.
Patients with these characteristics may have been more
likely to also adhere to recommendations from prevention
providers. Furthermore, the amount of risk reported by
these patients was fairly low and the degree of change
possible was therefore limited. Nevertheless, our study
yielded signiﬁcant results among patients receiving medi-
cal care provider- and prevention specialist-delivered
interventions. There would be a greater magnitude of
change possible with riskier patients and thus, our con-
clusions are likely conservative.
Conclusions are also limited by lack of standardization
of intervention content; each site chose and tailored its own
intervention. However, we are able to assure some level of
commonality across the types we included in this analysis
because sites were required to create and implement quality
assurance plans to ensure ﬁdelity to the intervention pro-
tocols. Study staff used a variety of techniques including
provider interview, observation and quizzes to ensure that
providers of all kinds adhered to the study protocols. In
addition, because this study provides data from ‘‘real
world’’ settings and implementation, the chances of repli-
cation of proven-effective interventions are enhanced.
Another limitation of our study is that the two sites using
medical care provider-delivered messages alone also
employed the use of computer-assisted risk assessment.
There is some evidence from the qualitative study [19] that
medical care providers remain uncomfortable with in-depth
discussions of patients’ sexual behavior. For this reason, it
is possible that the same degree of change would not have
been found if providers and not computers had conducted
the risk assessment. On the other hand, it does appear that
interventions using computer-aided risk assessment in
combination with medical-care provider delivered mes-
sages are an effective strategy for prevention with positives
programs. This ﬁnding supports other recently emerging
studies, such as those published by Gilbert and colleagues
[20] who note the value of a ‘‘Video Doctor.’’ In the Video
Doctor intervention, the computer performed both the risk
assessment and the counseling, with durable risk reduction
effects. Nevertheless, medical care providers in this study
welcomed the opportunity to discuss risk reduction with
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123their patients, an unintended consequence which cannot be
underestimated.
This study contributes to the growing evidence regard-
ing the effectiveness of prevention interventions for HIV-
infected people in clinical settings. Our results support
increased calls for the integration of prevention into care
settings and for more research to understand how inter-
vention ‘‘ﬁt’’ contributes to program success. This is the
ﬁrst published cross-site outcomes study from the SPNS
Prevention with Positives Initiative. Forthcoming papers
describing the ﬁndings of the qualitative study and the cost
effectiveness of interventions will provide additional evi-
dence for selection and implementation of prevention
models.
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